Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
Income from Continuing Operations
Novo Nordisk A/S
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Novo Nordisk A/S
CSE:NOVO B
|
Income from Continuing Operations
kr83.7B
|
CAGR 3-Years
26%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
H Lundbeck A/S
CSE:HLUN A
|
Income from Continuing Operations
kr2.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ALK-Abello A/S
CSE:ALK B
|
Income from Continuing Operations
kr486m
|
CAGR 3-Years
169%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Income from Continuing Operations?
Income from Continuing Operations
83.7B
DKK
Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's Income from Continuing Operations amounts to 83.7B DKK.
What is Novo Nordisk A/S's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
13%
Over the last year, the Income from Continuing Operations growth was 51%. The average annual Income from Continuing Operations growth rates for Novo Nordisk A/S have been 26% over the past three years , 17% over the past five years , and 13% over the past ten years .